Ibrutinib for the Treatment of AIHA in Patients With CLL/SLL or CLL-like MBL
Condition(s):Autoimmune Hemolytic Anemia; Chronic Lymphocytic Leukemia; Small Lymphocytic Lymphoma; Monoclonal B-Cell Lymphocytosis CLL-TypeLast Updated:December 1, 2023Recruiting